13 percent drop, that's dilution for you. CEO posted the below, still doesn't explain who received a majority of those shares, "consulting services"??? and still waiting on the Decembers dilution answer as that was the basis for the question. 15 million in unrestricted shares from 7 Dec to 22 Dec as listed on OTCmarkets.com
PART II - OTHER INFORMATION
Item 1A. Risk Factors
No material changes to risk factors have occurred as previously disclosed in Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2019, which was filed with the SEC on May 21, 2020.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
On March 2, 2020 we issued 8,333,333 shares of common stock for the partial conversion of $10,000 for a convertible note dated August 28, 2019.
On March 12, 2020 we issued 11,764,706 shares of common stock for the partial conversion of $10,000 for convertible note dated August 28, 2019.
On March 26, 2020 we issued 21,818,182 shares of common stock for the partial conversion of $12,000 for convertible note dated August 28, 2019.
On June 4, 2020, we issued 24,733,333 shares of common stock for the complete conversion of $29,680 for convertible note dated October 30, 2019.
On June 4, 2020, we issued 5,000,000 shares of common stock, valued at $0.0023 per share, for consulting services.
On June 4, 2020 we issued 70,000,000 shares of common stock, valued at $0.023 each to three officers and one director of the Company under a Restricted Stock Award.
On June 8, 2020, we issued 10,000,000 shares of common stock, valued at $0.0033 per share, for consulting services.
On June 9, 2020, we issued 18,292,818 shares of common stock for the complete conversion of $60,000 for convertible note dated June 9, 2020.
On June 11, 2020 we issued 40,000,000 shares of common stock, valued at $0.0046 each to three officers and one director of the Company under a Restricted Stock Award.
On June 15, 2020 we issued 3,000,000 shares of common stock, valued at $0.0017 each to one officer and one director of the Company under a Restricted Stock Award.
On June 15, 2020, we issued 10,000,000 shares of common stock, valued at $0.0023 per share, to the medical officer for consulting services.
On June 16, 2020, we issued 33,566,667 shares of common stock for the complete conversion of $40,280 for convertible note dated December 12, 2019.
On June 22, 2020, we issued 8,000,000 shares of common stock, valued at $0.0029 per share, for a donation in Triton Funds LP pursuant to the Donation Agreement (“DA”) and Registration Rights Agreement (“RRA”) dated January 24, 2020.
On June 25, 2020, we issued 10,000,000 shares of common stock, valued at $0.0083 per share, to the medical officer for consulting services.
On July 17, 2020 we issued 7,500,000 shares of common stock, valued at $0.0064 each to two officers, and one director of the Company under a Restricted Stock Award.
29
On July 17, 2020, we issued 2,000,000 shares of common stock, valued at $0.0064 per share, for consulting services.
On July 31, 2020 we issued 12,000,000 shares of common stock, valued at .0077 each to three officers, and one director of the Company under a Restricted Stock Award.
On August 4, 2020, we issued 8,969,230 shares of common stock for the complete conversion of $34,980 for convertible note dated February 4, 2020.
On August 26, 2020, we issued 10,000,000 shares of common stock, valued at $0.005 per share, for consulting services.
On September 23, 2020, we issued 1,000,000 shares of common stock, valued at $0.0085 per share, for consulting services.
On September 29, 2020, we issued 2,500,000 shares of common stock, valued at $0.0075 per share, for consulting services.
AI
